Chugai Receives Orphan Drug Designation for TECENTRIQ® in Small cell Lung Cancer and for Entrectinib in NTRK Fusion-positive Solid Tumors
2018-12-06
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.
Helpful links
Services
additional materials
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.